Observational studyResearch and practice in thrombosis and haemostasis2026
Efficacy and safety of recombinant activated factor VII for secondary prophylaxis in patients with Glanzmann thrombasthenia.
Pablo García-Jaén et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.